Anti-MET antibodies and compositions
US10450376B2 · kind B2 · utility
0Cited by
18References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2015 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Oct 29, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel recombinant antibodies directed against human MET (c-MET), as well as compositions comprising mixtures of at least two of said antibodies and use of the antibodies and antibody compositions for treatment of MET-mediated disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.